Xuemeng Xie

Pitavastatin suppressed liver cancer cells in vitro and in vivo

H. You, Wei-jian Zhang, Xuemeng Xie, 2016, OncoTargets and therapy.

Duodenal-jejunal bypass for the treatment of type 2 diabetes in Chinese patients with an average body mass index<24 kg/m2.

Xuemeng Xie, Jinfu Tu, F. Jiang, 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Schisantherin A suppresses interleukin-1β-induced inflammation in human chondrocytes via inhibition of NF-κB and MAPKs activation.

Xuemeng Xie, Shiyao Liao, Kai Zhou, 2016, European journal of pharmacology.

Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203

H. You, Wei-jian Zhang, Xuemeng Xie, 2016, In Vitro Cellular & Developmental Biology - Animal.

Design , synthesis , and biological evaluation of novel EF 24 and EF 31 analogs as potential i κ B kinase β inhibitors for the treatment of pancreatic cancer

Bingren, H. You, Xuemeng Xie, 2017 .

Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer

H. You, Xuemeng Xie, Bingren Hu, 2017, Drug design, development and therapy.

Downregulated pseudogene CTNNAP1 promote tumor growth in human cancer by downregulating its cognate gene CTNNA1 expression

Xuemeng Xie, C. Xing, Xiangjian Chen, 2016, Oncotarget.

Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma

Xuemeng Xie, Huajie Cai, Xiao-jiao Ruan, 2017, Oncology letters.